Navigation Links
China Medical Technologies Reports Third Quarter Financial Results
Date:2/28/2008

ding period of FY2006.

The Company's revenues are currently generated from three product lines, ECLIA diagnostic systems, FISH diagnostic systems and HIFU tumor therapy systems. ECLIA and FISH system sales include the sales of equipment and reagent kits.

ECLIA system sales for 3Q FY2007 were RMB96.7 million (US$13.3 million), representing a 74.4% increase from the corresponding period of FY2006. The strong year-over-year growth in the ECLIA system sales reflected the increasing utilization of ECLIA analyzers by hospitals and the introduction of new reagents, both of which drove increasing demand for reagent kits.

FISH system sales for 3Q FY2007 were RMB52.8 million (US$7.2 million) after the launch of our FISH systems in 1Q FY2007.

HIFU tumor therapy system sales for 3Q FY2007 were RMB115.6 million (US$15.9 million), representing a 9.0% increase from the corresponding period of FY2006. The year-over-year growth in this sector was driven primarily by increases in unit sales.

Gross margin decreased to 63.2% for 3Q FY2007 as compared to 72.6% for the corresponding period of FY2006. The decrease in gross margin was due to the amortization of FISH intangible assets of RMB18.2 million (US$2.5 million) and FISH equipment sales, which generated lower gross margin. Future FISH reagent sales will generate recurring revenue and higher gross margin for the Company. Excluding the impact of FISH amortization, gross margin would have been 70.0%.

Research and development expenses were RMB11.6 million (US$1.6 million) for 3Q FY2007, representing a 24.9% year-over-year increase. The increase was primarily due to the development of new ECLIA reagents and FISH reagents.

Sales and marketing expenses were RMB8.5 million (US$1.2 million) for 3Q FY2007, representing a 99.7% year-over-year increase. The increase was primarily due to the establishment and expansion of direct sales force for FISH systems and relevant promotional activities. '/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/-SentinelleMedicalInc.,aleadingmanufacturerofbr...esasuiteofnewleadingedgeclinicalapplicationsonitsA...RadiologicalSocietyofNorthAmerica(RSNA)annualmeeti...applicationsleveragetheuniquehighqualityimagesgene...pportmultipleimagingmodalitiesformulti-parametrica...
(Date:11/25/2009)...ents,Business,andPressJoinEfforttoEducate ,, M...ain,theNationalBipolarFoundationandtheMedicAlertFo...lStable"program,whichisnowbeingwidelyacceptedasapr...theNationalBipolarFoundationreceivedaproclamationo....GovernorofLouisianaMitchLandrieu.TheNationalBipol...
(Date:11/25/2009)...too short to draw definite conclusions, experts sa...ws) -- In diabetic patients with blocked coronary ...comes at one year whether patients undergo bypass ...archers report. , Bypass surgery has been the s...ary artery disease. However, less invasive approac...
(Date:11/25/2009)... few signs of trouble with the H1N1 vaccine, , ...he ongoing H1N1 swine flu pandemic may be driving ...er patients, a U.S. health official said Wednesday...ococcal infections around the country," Dr. Anne S...ization and Respiratory Diseases at the U.S. Cente...
(Date:11/25/2009)...al cancer also can reverse a rare stomach disorder...he disease, researchers at Vanderbilt University M...se causes thickening of the stomach lining, severe...nemia and swelling in the feet and ankles due to p...stric cancer. Previously, the only effective treat...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
..., 2008 With over 60 million Americans diagnosed w...r diabetes, cardiovascular events and other obesit...ulations avoid these complications is an important...ty School of Medicine report that organizations su...
...t. 8 Cardica, Inc.,(Nasdaq: CRDC ) today announc.... Eastern Time tomorrow, September 9, to provide a...omosis System., Conference Call Details, To acce...is 57153283. Please dial in approximately 10 minut...
...ber 08, 2008 Infantile spasms are a severe and po... children aged typically 4-8 months. In a new stud... that the ketogenic diet, a high fat, low carbohyd...e first description of the ketogenic diet as a fir...
...nation faces,challenges in utilizing Earth science...c health, according to a NASA-sponsored report iss...ram., The report examines the computer-based deci...ble energy resources, water,management, and the pr...
... second year in a row Inc.,recognized Vickie Milaz...Growing Private Companies in America. The Inc. 500... list, highlights businesses that are too,big to g....S. economy.", In addition to the Inc. Top 5000 r...
...ain shrinkage, study shows , , MONDAY, Sep...w levels of vitamin B12 seem to be at increased ri...rch suggests. , Brain atrophy is associated with A...ls of B12 actually cause brain atrophy, they do ...
Other Medicine News:Health News:Community-based diabetes prevention program shows promise 2Health News:Cardica to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Provide Positive Update on Pas-Port(R) 2Health News:Diet may eliminate spasms for infants with epilepsy 2Health News:Report Explores Use of Earth Data to Support National Priorities 2Health News:Report Explores Use of Earth Data to Support National Priorities 3Health News:Vickie Milazzo Institute Makes Inc.'s List of Top 5000 Fastest-Growing Private Companies in America 2Health News:Vitamin B12 Key to Aging Brain 2Health News:Vitamin B12 Key to Aging Brain 3
(Date:11/25/2009)...swire/--RemediumTechnologiesInc.,acompanydevelopin...firstprizeand$10,000intheMostPromisingSecurityIdea...ficialsannouncetoday. ,, Selectedfrommorethan10...eirinventionattheGSCSecuritySummitconferenceheldat...ediumtechnologies.com )isdevelopingahigh-pressuref...
(Date:11/25/2009)...stCall/--ChinaSkyOne,Medical,Inc.("ChinaSkyOneMedi...ntegratedpharmaceuticalcompanydevelopingandproduci...na("PRC"),today,announcedthattheCompanyrecentlypas...maceuticalandBiologicalProducts("ICPBP")examinatio...rostateSpecific,Antigen(ColloidalGold)anditsDeterm...
(Date:11/25/2009)...tCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalproduct...tems,announcedtodaythatClintSeverson,chairmanandch...rJaffrayHealthCareConferenceonWednesday,December2,...rkPalaceHotelinNewYorkCity. ,, AboutAbaxis ,...loodanalysissystemsforuseinanyveterinaryorhumanpat...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3According to Excel Physical Therapy and Fitness Awareness Still Low for Law that Allows People to go Directly to a Physical Therapist without a Docto 58347 1According to Excel Physical Therapy and Fitness Awareness Still Low for Law that Allows People to go Directly to a Physical Therapist without a Docto 58347 2According to Excel Physical Therapy and Fitness Awareness Still Low for Law that Allows People to go Directly to a Physical Therapist without a Docto 58347 3Does Helicobacter pylori eradication therapy prevent gastric cancer 3F 58344 1Does Helicobacter pylori eradication therapy prevent gastric cancer 3F 58344 2Environmental health chief in Milwaukee to hear citizen concerns 10107 1Environmental health chief in Milwaukee to hear citizen concerns 10107 2
... Primary Efficacy Endpoint Met in Stage 1 of Two-S...- 100% of Evaluable Patients to Date Continue to S...or Stable Disease -, TUSTIN, Calif., July 2 Pere... reported that its lead product,candidate bavituxi...point,in its ongoing Phase II clinical trial in pa...
...s show promise for ,buying time, in victims of let...TTLE, July 1 For the first time, researchers have...ounts of inhaled or,intravenous hydrogen sulfide, ...r sulfurous stench -- significantly improves survi...ist Mark B. Roth, Ph.D., and colleagues in the Bas...
Other Medicine Technology:Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 2Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 3Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 4'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss 2'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss 3
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: